1st Quarter - Report

BIOCOM for BIOCOM

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$57,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2011 $57,000 Replaced
1st Quarter - Amendment May 1, 2011 $57,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R.734: To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes. This bill repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. HR 436: Protect Medical Innovation Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices.

LobbyistCovered position, as disclosed
MADELEINE BAUDOIN —
JOE PANETTA —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 734 (112th), H.R. 436 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.